Prevalence of drug-related problems and cost-savings opportunities in Medicaid high utilizers identified by a pharmacist-run drug regimen review center

Journal of Managed Care Pharmacy

Volumn 12, Issue 8, 2006, Pages 677-685

  LaFleur, Joanne ^a,b   McBeth, Carrieann ^a   Gunning, Karen ^a   Oderda, Lynda ^a   Steinvoort, Carin ^a   Oderda, Gary M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b NONE   (United States)

Author keywords

Drug utilization review; Drug related problems; Health policy; Medicaid; Therapeutic duplications

Indexed keywords

ACICLOVIR; ADRENALIN; AMFEBUTAMONE; AMITRIPTYLINE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARISOPRODOL; CIPROFLOXACIN; CITALOPRAM; DIPHENHYDRAMINE; ERYTHROMYCIN; HYDROCHLOROTHIAZIDE; HYDROCODONE; HYOSCYAMINE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; PARACETAMOL; PAROXETINE; PROMETHAZINE; PROPRANOLOL; QUETIAPINE; ROSUVASTATIN; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN; THEOPHYLLINE; THIORIDAZINE; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE; DRUG;

ADULT; AGED; ARTICLE; BLURRED VISION; CONFUSION; CONTROLLED STUDY; COST CONTROL; DRUG INDUCED DISEASE; DRUG INHIBITION; DRUG POTENTIATION; DRUG USE; FEMALE; GENITAL HERPES; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HEART ARREST; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MUCOSAL DRYNESS; MUSCULOSKELETAL DISEASE; PHARMACIST; PRESCRIPTION; QT PROLONGATION; RECOMMENDED DRUG DOSE; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; TORSADE DES POINTES; TREATMENT DURATION; UNITED STATES; UNSPECIFIED SIDE EFFECT; URINE RETENTION; DRUG COMBINATION; MIDDLE AGED; PHARMACY; POLYPHARMACY; STATISTICS;

AGED; AGED, 80 AND OVER; COST SAVINGS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MEDICAID; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; POLYPHARMACY; UTAH;

EID: 33847245521     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2006.12.8.677     Document Type: Article

References (25)

1. Omnibus Budget Reconciliation Act of 1990. In: P.L. 101-508; S4401, 1927(g) (November 5, 1990) and OBRA 90 Regulations. Federal Register. November 2, 1992;57FR(212):49397-49401.
2. Rascati KL, Okano GJ, Burch C. Evaluation of physician intervention letters. Med Care. 1996;34(8):760-66.
3. Smith DH, Christensen DB, Stergachis A, Holmes G. A randomized controlled trial of a drug use review intervention for sedative hypnotic medications. Med Care. 1998;36(7):1013-21.
4. Laine C, Hauck WW, Turner BJ. Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users. Med Care. 2002;40(10):976-95.
5. Coleman CI, Reddy P, Laster-Bradley NM, Dorval S, Munagala B, White CM. Effect of practitioner education on adherence to asthma treatment guidelines. Ann Pharmacother. 2003;37(7-8):956-61.
6. Stempel DA, Durcannin-Robbins JF, Hedblom EC, Woolf R, Sturm LL, Stempl AB. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists. Ann Allergy Asthma Immunol. 1996;76(2):153-58.
7. Hennessy S, Bilker WB, Zhou L, et al. Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA. 2003;290(11):1494-99.
8. Brown CM, Lipowski EE. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program. Am J Hosp Pharm. 1993;50(9):1898-1902.
9. Stuart B, Briesacher BA, Ahern F, et al. Drug use and prescribing problems in four state Medicaid programs. Health Care Financ Rev. 1999;20(3):63-78.
10. Briesacher BA, Stuart B, Peluso R. Drug use and prescribing problems in the community-dwelling elderly: a study of three state Medicaid programs. Clin Ther. 1999;21(12):2156-72.
11. Okano GJ, Rascati KL. Effects of Medicaid drug utilization review intervention letters. Clin Ther. 1995;17(3):525-33; discussion 16.
12. Rascati K. Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clin Ther. 1995;17(4):786-90.
13. Monette J, Mogun H, Bohn RL, Avorn J. Concurrent use of antiulcerative agents. J Clin Gastroenterol. 1997;24(4):207-13.
14. Schumock G, Brundage G, Chapman M, et al., eds. Pharmacotherapy Self-Assessment Program. 5th ed. Kansas City, MO: American College of Clinical Pharmacy; 2005.
15. Fischer MA, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res. 2003;38(4):1051-63.
16. Bertakis KD, Azari R, Helms LL, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49:147-52.
17. National Center for Health Statistics. Table 27. Life expectancy at birth, at 65 years of age, and at 75 years of age, according to race and sex, 2003. Available at: www.cdc.gov/nchs/data/hus/tables/2003/03hus027.pdf. Accessed August 1, 2004.
18. Hamer AM, Hartung DM, Haxby DG, et al. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program. J Manag Care Pharm. 2006;12(6):449-56. Available at: http://www.amcp.org/ data/jmcp/research_449-456.pdf. Accessed October 12, 2006.
19. Soumerai SB, Ross-Degnan D. Experience of state drug benefit programs. Health Aff. 1990;9(3):36-54.
20. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc. 2003;289(10):2560-72.
21. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2006;29(suppl 1):S4-S42.
22. National Institutes of Health, National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed October 12, 2006.
23. Hunt S, Baker D, Chin M, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology. Available at: http://www.acc.org. Accessed October 12, 2006.
24. The North American Menopause Society. Role of progestogens in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopause. 2003;10(2):113-32.
25. Drug Regimen Review Center Annual Report. Table 2 - Cost savings. Updated 2005. Available at: http://www.utahdrrc.org/annrep.htm. Accessed October 12, 2006.